Showing results (11-20 of 624) with videos related to
Sort By:
Pageof 63
Zeitschrift Fur Rheumatologie|August 13, 2010
[Tocilizumab. What comes after TNF-blockers in clinical routine?]P Roll, A Rubbert-Roth, H-P TonyZeitschrift Fur Rheumatologie|January 14, 2018
[Lymphoma in rheumatic diseases]A Rubbert-Roth, J T Bittenbring, G AssmannZeitschrift Fur Rheumatologie|March 25, 2014
[Recommendations for use of rituximab in patients with rheumatoid arthritis]A Rubbert-Roth, G R Burmester, T Dörner, et al.Zeitschrift Fur Rheumatologie|May 25, 2010
[Recommendations of the German rheumatology society on the use of tocilizumab in rheumatoid arthritis]A Gause, A Rubbert-Roth, H Michels, et al.Zeitschrift Fur Rheumatologie|June 24, 2011
[Is it possible to compare different studies on efficacy of biologicals in patients with rheumatoid arthritis? : mixed treatment comparison as a new tool for indirect comparison of clinical studies]K Krüger, B Hellmich, A Rubbert-Roth, et al.Zeitschrift Fur Rheumatologie|February 4, 2016
[Lung cancer and rheumatoid arthritis. An interdisciplinary challenge]A Rubbert-Roth, T Zander, C Kneitz, et al.Zeitschrift Fur Rheumatologie|November 20, 2010
[§ 116b SGB V (social insurance code, book five) for rheumatology patients. An empirical assessment on the basis of administrative data]T Rath, E Bokern, E Sefo-Bukow, et al.Clinical and Experimental Dermatology|November 8, 2021
Treatment of refractory subacute cuataneous lupus erythematosus with baricitinibL Joos, F Vetterli, T Jaeger, et al.Annals of the Rheumatic Diseases|December 29, 2010
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)Gerd R Burmester, E Feist, H Kellner, et al.Zeitschrift Fur Rheumatologie|October 8, 2011
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis]J R Kalden, H Burkhardt, B Buss, et al.Pageof 63